Food quality induces a miscible disease with relevance to Alzheimer’ s disease and neurological diseases by Martins, Ian J.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
2016 
Food quality induces a miscible disease with relevance to 
Alzheimer’ s disease and neurological diseases 
Ian J. Martins 
Edith Cowan University, i.martins@ecu.edu.au 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Medicine and Health Sciences Commons 
10.5539/ jfr. v5n6p 45 
Martins, I. J. (2016). Food quality induces a miscible disease with relevance to Alzheimer’s disease and 
Neurological diseases. Journal of Food Research, 5(6), 45. Available here 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/3400 
Journal of Food Research; Vol. 5, No. 6; 2016 
ISSN 1927-0887   E-ISSN 1927-0895 
Published by Canadian Center of Science and Education 
45 
 
Food Quality Induces a Miscible Disease with Relevance to 
Alzheimer’s Disease and Neurological Diseases 
I. J. Martins 1, 2, 3 
1Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan 
University, 270 Joondalup Drive, Joondalup, 6027, Australia 
2School of Psychiatry and Clinical Neurosciences, The University of Western, Australia 
3McCusker Alzheimer's Research Foundation, Holywood Medical Centre, 85 Monash Avenue, Suite 22, 
Nedlands, 6009, Australia 
Correspondence: Dr Ian J Martins, School of Medical Sciences, Edith Cowan University, 270 Joondalup Drive, 
Joondalup, Western Australia 6027, Australia. Tel: 61-863-042-574. E-mail: i.martins@ecu.edu.au 
 
Received: August 30, 2016     Accepted: September 12, 2016     Online Published: October 14, 2016 
doi:10.5539/jfr.v5n6p45          URL: http://dx.doi.org/10.5539/jfr.v5n6p45 
 
Abstract 
Food and nutrition guidelines for the handling and processing of fresh fruit, bread, and vegetables are essential 
and fresh produce may require cold preservation procedures to prevent minimal bacterial and fungi 
contamination of food. Bacterial lipopolysaccharides (LPS) corrupt lipoprotein and amyloid beta (Aβ) 
metabolism in diabetes, Alzheimer’s disease (AD) and various neurological diseases. In the developing world the 
increased plasma LPS levels induce non-alcoholic fatty liver diseases and interfere with albumin and Aβ 
interactions with spontaneous Aβ oligomer formation in the cerebrospinal fluid and brain that leads to neuron 
apoptosis by inactivation of Starling’s equation that is responsible for the maintenance of hydrostatic and oncotic 
pressure with relevance to fluid balance. In the developing world increased levels of LPS, mycotoxin and 
xenobiotics lead to irreversible neurological diseases by inhibition of Starling’s equation for maintenance of 
oncotic/osmotic pressure that lead to neuron senescence or apoptosis. In the developed world nutrigenomic diets 
are required that prevent Sirtuin 1 gene repression and maintain neuron survival that links the brain and 
peripheral hepatic monomer Aβ metabolism. The maintenance of blood-cerebrospinal fluid capillary transport of 
albumin and monomer Aβ is relevant to stabilization of neurons not only in Alzheimer’s disease but also in Type 
3 diabetes and various neurological diseases. Healthy diets reverse the inhibition of brain to peripheral Aβ 
transport that is sensitive to Starling’s equation for regulation of central nervous system hydrostatic and oncotic 
pressure with the prevention of diabetes, various neurological diseases and Alzheimer’s disease. 
Keywords: diet, lipopolysaccarides, albumin, Starling equation, amyloid beta, neurologic disease, Alzheimer’s 
disease, diabetes 
1. Introduction 
The gene-environment interaction may indicate a population’s risk to chronic disease progression with effects of 
diet that may override genomic expression in populations. In the developing and developed world the United 
States of America may be a good example of populations that include Caucasians, African Americans, Hispanics, 
Native Americans, Pacific Islanders or Asians for assessment for neurological diseases. Neurological diseases 
include Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s disease, autism and neurodevelopmental 
disorders, neuromuscular disorders/peripheral neuropathies and neurobehavioural disorders. Neurodegeneration 
is referred to as the accelerated aging of neurons leading to alterations in shape, size and stability of neurons in 
these neurological diseases.  
Interests in premature aging, food and nutrition science may assist in the understanding of diets involved with 
brain astrocyte aging essential for neuronal survival (Martins & Creegan, 2014; Rodríguez-Arellano et al, 2016). 
Neurons and various cells in the body synthesize amyloid beta a monomeric 4 kd peptide that is extremely 
susceptible to self-aggregation as toxic oligomer species (Yun et al, 2007) and spontaneous fibril formation and 
transport of the monomeric amyloid beta (Aβ) species from the brain across the blood brain barrier to the plasma 
compartment is required for rapid metabolism to the liver (Martins, 2015).  
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In AD and various other neurological diseases such as a miscible chronic disease that involves Type 3 diabetes 
(Martins, 2015) may lead to early aging with neuron senescence and associated with food quality and safety 
(Martins, 2015). Interest in the calorie sensitive gene Sirtuin 1 (Sirt 1) (Herskovits & Guarente, 2014; Tang & 
Chua, 2008, Guarente, 2007, Hansen & Connolly, 2008) have accelerated with relevance to food and nutrition 
with its downregulation associated with neuron senescence, circadian rhythm abnormalities with relevance to 
defective Aβ metabolism in various neurological diseases. Sirt 1 is a NAD(+) dependent class III histone 
deacetylase protein that targets transcription factors to adapt gene expression to metabolic activity, insulin 
resistance and inflammation in chronic diseases. Nutritional regulation (calorie restriction) of Sirt1 is involved in 
neuron proliferation with effects on cellular cholesterol closely linked to Aβ clearance in AD (Martins, 2015). 
Microbiological spoilage of food in the developing world has become important with unsafe food that contains 
harmful bacteria (WHO/Food safety, 2015). Microbiological contamination of food can occur at the place of 
production or at the market place and home. Unsafe gram negative bacteria may reside in unpasteurized milk, 
undercooked meat and fresh fruits and vegetables that are poorly distributed or stored. Delayed transport of food 
products may allow temperature related modification of food production, storage and distribution with high 
bacterial/fungal contamination (Hymery, et al, 2014; Makun, 2013; Leff & Fierer, 2013; Howel, 1912). Many 
publications in the developed world indicate that hypercholesterolemia is connected obesity, Type II diabetes and 
neurological diseases and numerous studies have linked defective high density lipoprotein (HDL) metabolism to 
cardiovascular disease and neurodegeneration (Hottman et al. 2014). Food quality and food science has now 
become important to determine the effects of ingested food that contain microbiological contamination on 
defective HDL cholesterol metabolism and the induction of non alcoholic liver disease (NAFLD) that has 
reached epidemic levels in the world (Younossi et al. 2016). 
Lipopolysaccarides (LPS) are endotoxins and essential components of the outer membrane of all Gram-negative 
bacteria. LPS from bacteria share common features in their basic architecture and consists of three covalently 
linked segments, a surface carbohydrate polymer (O-specific chain), a core oligosaccharide featuring an outer 
and inner region and an acylated glycolipid (termed Lipid A). The O-specific chain shows the most diversity and 
Lipid A anchors the LPS molecule in the Gram-negative outer membrane and is most conserved in bacteria 
species. LPS can rapidly insert into cell membranes with a preference for insertion and partition into 
cholesterol/sphingomyelin domains in cell membranes (Martins, 2015; Ciesielski et al, 2012). LPS has been 
associated with repression of the anti-aging gene Sirt 1 with relevance to metabolic diseases, NAFLD, diabetes 
and Alzheimer’s disease (Martins, 2015; Martins, 2015; Martins, 2016; Martins, 2016; Martins, 2016). 
Dietary fat increase plasma endotoxins such as LPS into the blood plasma (Feingold et al, 1992;Miele, et al, 2013; 
Le Roy et al, 2013; Alisi, et al, 2012; Duseja, et al, 2014) that bind to LPS binding proteins, lipoproteins and cell 
receptors (Fenton & Golenbock, 1998). Lipoproteins such as chylomicron that are produced after taking a meal 
high in fats contain the LPS binding protein (LBP) that bind LPS and are essential for interactions of LPS to apo 
B containing cholesterol-rich lipoproteins (chylomicron remnants, very low density lipoproteins, high density 
lipoproteins). Interest in LPS in relation to dyslipidemia has escalated with relevance to the neutralization of apo 
E by binding of LPS (amphipathic α-helix organization) and the toxic effects of LPS are neutralized in the body 
by rapid transport to the liver for metabolism (Martins, 2015). Increased plasma LPS elicit hepatic release of 
cytokines and acute phase proteins (APP) and lipoproteins such as HDL that contain apo E and apolipoprotein AI 
(apo AI) may classically be involved in the modulation of the inflammatory response that involve the liver and 
immune cells (Martins, 2015).  
Interactions between HDL and lipoproteins (chylomicrons, very low density lipoproteins, low density 
lipoproteins) with relevance to cholesterol transport that involve lipid transfer proteins such as cholesterol ester 
transport proteins and phospholipid transport proteins has become important with relevance to LPS and its 
interactions with phospholipid and cholesterol transport to lipoproteins and cell membranes (Martins, 2015; 
Martins, 2016). Interactions between LPS and apo AI have also been reported with effect on LPS on 
inflammatory responses and diminished by apo AI function with detrimental effects on HDL and reverse 
cholesterol transport (Henning et al, 2006;Wang et al, 2008; Gupta et al, 2005). Therefore LPS has detrimental 
effects on HDL metabolism and reverse cholesterol transport that involve neutralization of apo E and apo AI 
with the induction of dyslipidemia and NAFLD.  
2. Amyloid Beta Metabolism Is Defective in Alzheimer’s Disease and Neurological Diseases and Associated 
with Chronic Diseases 
The role of cholesterol in modulating the expression of amyloid precursor protein (APP) and the levels of cell Aβ 
have been reported. The cholesterol receptors low density receptor related protein 1 (LRP-1) and low density 
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lipoprotein receptor (LDL r) act on the blood brain barrier (BBB) and regulate the transport of Aβ from the brain 
to the periphery (Martins, 2015). In chronic diseases such as obesity and diabetes excessive food intake may 
increase plasma LPS levels with interference with Sirt 1’s circadian regulation (Martins, 2016) of Aβ metabolism 
by corruption of peripheral plasma Aβ metabolism in both Alzheimer’s disease and various neurological diseases 
(Erickson et al, 2012). In various neurological diseases the transport of Aβ is corrupted with several reports of 
BBB disorders associated with neurodegenerative diseases (Rosenberg, 2012; Kanwar, et al, 2012). 
Sirt 1 is also responsible for alpha-synuclein metabolism with alpha-synuclein important to interactions with 
cholesterol in cell membranes relevant to Aβ metabolism (Martins, 2015). Albumin has been shown to bind Aβ 
and LPS with levels of LPS being reported to decrease in plasma albumin levels. The plasma, CSF and the brain 
Aβ’s self aggregation properties can be determined by the levels of albumin and vitamin E levels with the 
circadian variations of CSF protein (Nilsson, et al, 1992) under the influence of Sirt 1. CSF in neurological and 
AD individuals contain apo E with essential involvement in amyloid beta clearance and metabolism (Hesse et al., 
2000; Cruchaga et al., 2012). LPS is involved with the neutralization of apo E and the induction of NAFLD 
(Martins, 2015; Harte et al., 2010; Miele et al., 2013) with lower CSF albumin levels and inactivated apo E 
associated with defective CSF transport of amyloid beta relevant to accelerated amyloid beta aggregation in the 
CSF. The interest in CSF Aβ metabolism in diabetes (Kobessho, et al, 2008; Manschot, et al, 2008) and 
neurological diseases has accelerated with neurological disease now linked primarily to dietary LPS plasma 
levels, insulin resistance and accelerated Aβ aggregation. 
Research in the role of LPS in the peripheral sink Aβ hypothesis (Martins, 2015) has escalated with the improved 
understanding of the LPS effects on astrocytes and neurons in the brain and effects on the transport across the 
blood brain barrier (BBB). LPS has been associated with impaired Aβ efflux across the BBB with the 
downregulation of the (LRP-1) that has previously been shown to be critical to the Aβ efflux from the brain (Lee 
et al., 2008). The effects of systemic LPS on disturbed Aβ homeostasis are relevant to Aβ generation (Lee et al., 
2008; Llewellyn et al., 2010). Activation of inflammation in astrocytes by LPS corrupt the important role of 
astrocytes in the metabolism of neuronal Aβ (24) with the development of AD. In the brain the CD14 receptor is 
referred to as the LPS receptor and involved with Aβ metabolism (Martins & Creegan, 2014). LDL receptor 
deficiency was associated with astrocytosis with increased amyloid deposition and implicate LPS and 
interactions with the LDLr in astrocyte-neuron Aβ metabolism (Martins, 2015; Martins & Creegan, 2014). 
The Starling equation (Starling, 2016) indicates the movement of fluid across membranes by calculation of 
hydrostatic and oncotic pressure that involve the blood: CSF barrier and CSF: blood brain barrier (Feingold et al, 
1992;Miele, et al, 2013; Le Roy et al, 2013; Alisi, et al, 2012; Duseja, et al, 2014). In the Starling equation as 
shown below the reflection coefficient (sigma) is a correction factor that indicates changes in the oncotic 
pressure as a result of protein changes in the CSF compartment. Cappillary membranes do not allow large 
molecular weight proteins to pass into the CSF compartment but albumin and monomeric Aβ has access to the 
CSF compartment to maintain the oncotic pressure. 
The adapted Starling equation () reads as follows: 
 
where: 
 is the net fluid movement between compartments. 
 is the net driving force,  
o Pc is the capillary hydrostatic pressure 
o Pi is the interstitial hydrostatic pressure 
o πc is the capillary oncotic pressure 
o πi is the interstitial oncotic pressure 
o Kf is the filtration coefficient – a proportionality constant 
o σ is the reflection coefficient 
The reflection coefficient correction factor will change when LPS arrives into the plasma/ CSF compartment by 
a reduction in albumin and spontaneous aggregation of Aβ (Figure 1) with complete corruption of the peripheral 
clearance Aβ pathway (Martins, 2015) relevant not only to Alzheimer’s disease but also to diabetes and various 
neurological diseases. LPS will change membrane fluidity (Martins 2015; Martins, 2016) with effects on the 
filtration coefficient of the Starling equation at the blood:CSF barrier and CSF:blood brain barrier with 
corruption of the influx and efflux of Aβ (Martins, 2016). LPS effects on brain membrane fluidity (Figure 1) 
supersede phospholipid and monomer Aβ membrane interactions with the promotion of non-Brownian Aβ 
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dynamics in the plasma, CSF and brain (Martins, 2015; Martins, 2016). Effects of LPS on Aβ transport involve 
alpha synuclein with effects on membrane fluidity that involve cholesterol (Martins, 2015) and Aβ oligomers in 
the CSF and brain with LPS involved in the transformation of membranes in capillaries that override the 
filtration coefficient that determines protein (albumin/Aβ) transport in the CSF and brain (Figure 1).  
 
Figure 1. Unhealthy diets increase LPS levels with effects in the cerebrospinal fluid that promote amyloid beta 
aggregation with corruption of membrane fluidity (blood:CSF barrier and CSF:blood brain barrier) and do not 
allow the passage of essential proteins such as albumin into the CSF. LPS effects on Starling equation is 
associated with increased oncotic pressure and associated with defects in the brain transport of amyloid beta 
from the CNS via the cerebrospinal fluid into the plasma for metabolism by the liver. 
The effects of bacterial LPS to chronic disease may be linked to developing or third world countries associated 
with poor hygiene standards and poor food storage and corruption of Starling Law may lead to irreversible 
autonomous disease associated with central nervous system fluid balance dyshomeostasis (Feingold et al, 
1992;Miele, et al, 2013; Le Roy et al, 2013; Alisi, et al, 2012; Duseja, et al, 2014). LPS in these developing 
countries repress Sirt 1 expression and completely inactivate the brain from the periphery with a defect in Aβ 
metabolism. In these developing countries mycotoxin (Martins, 2015) and xenobiotics levels (Martins, 2013) 
found in food and water may be elevated and may further induce CSF Aβ aggregation and elevated oncotic 
pressure diseases (Martins, 2013). Sirt 1 is a calorie sensitive gene and in the developed world nutrigenomic 
diets (Sirt 1 upregulation) may be appropriate to reverse circadian rhythm abnormalities with effects on 
improved peripheral amyloid beta metabolism with decreased CSF amyloid aggregation and improvements in 
calculations for the Starling equation by CNS albumin and amyloid beta transport with relevance to fluid 
transport to the brain (Starling, 2016; Buishas et al, 2014). Dietary intake in the developing and developed world 
in various chronic and neurologic diseases need dietary modifications with lifestyle changes to allow reversal of 
defective Aβ metabolism and physiological fluid balances that are essential for neuron survival and reversal of 
accelerated aging. 
3. Food Quality and the Nature of Diet Maintains Post-Prandial Lipid and Amyloid Beta Metabolism 
Relevant To Diabetes and Neurological Diseases 
The consumption of the very low carbohydrate and low fat diets (Martins, 2015) are required to prevent LPS 
absorption and prevent LPS repression of the anti-aging gene Sirt 1 that is now linked to the defective 
gene-environment interactions involved in defective liver cholesterol metabolism (post-prandial) associated with 
insulin resistance, NAFLD disturbed brain Aβ transport in various neurological diseases. Furthermore, healthy 
diets that maintain LPS and protein interactions with proteins such as albumin, lactoferrin and transferrin and 
other acute phase proteins/glycoasminoglycans delay LPS induced Aβ toxic oligomer formation connected to 
neuron number important to thinking and intelligence (Martins, 2016).  
In obesity and diabetes the LPS level in the blood plasma are elevated and related to hyperglycemia and NAFLD 
(Harte et al., 2010; Miele et al., 2013). In the developing and developed world dairy products such as French 
cheese and yoghurt (Arslan et al. 2011; Coton et al., 2011; Hickey et al., 2015) should be consumed as 
recommended by food safety practices. Gram negative bacteria such as E Coli and Pseudomonas aeruginosa 
(Arslan et al. 2011) can be involved in the fermentation and food spoilage that release LPS into the intestine. 
Diets that are high in fat and cholesterol stimulate LPS absorption (Huang, et al.; 2007 Lee, 2013) with increased 
risk for NAFLD (Harte et al., 2010; Miele et al., 2013). Dairy foods such as cheese and yogurt may involve 
many variables that include the milk preparation and temperature (storage, light, time). Modern technologies that 
involve freezers with safe storage time and lifetime in the food industry do not allow for microbiological 
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contamination (gram negative bacteria) in the developed world compared with the developing world. 
The potent effects of apple and cheese spoilage produces the mycotxon patulin that can be concentrated in the 
brain and liver with the corruption of the apo E mediated clearance of Aβ induced by patulin with relevance to 
post-translational modification of proteins (Martins, 2015). Ochratoxin A (OTA) is found in the rind and inner 
part of the cheese, coffee and in alcohol (beer, wine) and can lead to increased OTA to the brain with neuron 
apoptosis. Alcohol (apple cocktail, beer, wine) promotes the intestinal absorption of LPS and myoctoxin and 
alcohol is a Sirt 1 inhibitor with relevance to corruption of the brain and peripheral regulation of Aβ metabolism. 
Stress and lifestyle changes may induce an apelinergic dysfunction (Martins, 2015) with individuals in the 
developing world more susceptible to CSF Aβ aggregation associated with the absence of the brain to peripheral 
links in hepatic Aβ metabolism. 
Activators of Sirt 1 (nutrigenomic diets) are required such as leucine, pyruvic acid and magnesium (Martins, 
2016) that maintain hepatic and brain Sirt 1 activity to prevent delayed hepatic cholesterol and brain Aβ 
metabolism with relevance to Type 3 diabetes and NAFLD (Martins, 2016). Excessive phosphatidylinositol 
doses (gm/day) (Martins, 2015) need to be administered to individuals in the developing world to reverse plasma, 
CSF and brain Aβ aggregation with phosphatidylinositol doses important to therapeutic effects on membrane 
stability and fluid filtration. Central acting CNS drugs to maintain oncotic/osmotic pressure in diabetes and 
various neurological diseases need to be consumed with excellent food quality to prevent 
LPS/mycotoxin/xenobiotic ill effects (Martins, 2015; Martins, 2016). LPS/mycotoxin contamination can be 
associated with the packing, storage, transportation, handling, and processing of fresh produce to the final 
destination needs to be assessed carefully.  
4. Conclusion 
In the developing and developed world the induction of NAFLD, diabetes, neurological diseases and 
Alzheimer’s disease is now connected to the handling and processing of food and may require cold preservation 
procedures to prevent minimal bacterial and fungi contamination. The peripheral sink clearance Aβ pathway that 
is critical to maintain neuron survival is inactivated by increased plasma/CSF contents of LPS and mycotoxin 
with complete nullification of Starling’s equation for hydrostatic and oncotic pressure regulation in the brain 
with relevance to the developing world. The brain and peripheral links to hepatic Aβ metabolism is now very 
important not only to Alzheimer’s disease but to various neurological diseases, Type 3 diabetes, NAFLD. In the 
developing world the gene-environment effects may not include the participation of the anti-aging gene Sirt 1 
that is responsible for the maintenance of CSF circadian rhythm, neuron proliferation and peripheral Aβ 
metabolism. LPS downregulates Sirt 1 and corrupts the Starling forces by interference with capillary membrane 
fluidity and the regulation of albumin levels relevant to toxic Aβ and alpha-synuclein formation in the CSF and 
brain. Peripheral Aβ metabolism is now relevant to diabetes and various neurological diseases and reversal of 
neurological diseases/Alzheimer’s disease in the developed world now involves a healthy diet that promotes the 
rapid Aβ transport from the brain to the CSF for rapid metabolism to the liver. 
Acknowledgements 
This work was supported by grants from Edith Cowan University, the McCusker Alzheimer's Research 
Foundation and the National Health and Medical Research Council and the CRC. 
References 
Alisi, A., Ceccarelli, S., Panera, N., & Nobili, V. (2012). Causative role of gut microbiota in non-alcoholic fatty 
liver disease pathogenesis. Frontiers in Cellular Infection Microbiology, 2, 132.  
http://dx.doi.org/10.3389/fcimb.2012.00132 
Arslan, S., Eyi, A., & Özdemir, F. (2011) Spoilage potentials and antimicrobial resistance of Pseudomonas spp. 
isolated from cheeses. J Dairy Sci. 94, 5851-6. http://dx.doi.org/10.3168/jds.2011-4676 
Bertelsen, S., Hinrichs, A., Fagan, A. M., Holtzman, D. M., Morris, J. C., & Goate, A. M. (2012) Cerebrospinal 
fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Genet. 21, 
4558-71. http://dx.doi.org/10.1093/hmg/dds296 
Blennow, K. (2000) Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem Res. 25, 511-7. 
http://dx.doi.org/10.1023/A:1007516210548 
Buishas, J., Gould, I. G., & Linninger, A. A. (2014). A computational model of cerebrospinal fluid production and 
reabsorption driven by Starling forces. Croation Medical Journal, 55, 481-97.  
http://dx.doi.org/10.3325/cmj.2014.55.481 
http://jfr.ccsenet.org Journal of Food Research Vol. 5, No. 6; 2016 
50 
 
Ciesielski, F., Davis, B., Rittig, M., Bonev, B. B., & O'Shea, P. (2012). Receptor-Independent Interaction of 
Bacterial Lipopolysaccharide with Lipid and Lymphocyte Membranes; the Role of Cholesterol. PLoS ONE, 7, 
e38677. http://dx.doi.org/10.1371/journal.pone.0038677 
Coton, M., Delbés-Paus, C., Irlinger, F., Desmasures, N., Le Fleche, A., Stahl, V., Montel, M. C., & Coton E. (2012) 
Diversity and assessment of potential risk factors of Gram-negative isolates associated with French cheeses. 
Food Microbiol. 29, 88-98. http://dx.doi.org/10.1016/j.fm.2011.08.020 
Cruchaga, C., Kauwe, J. S., Nowotny, P., Bales, K., Pickering, E. H., Mayo, K., Duseja, A., & Chawla, Y. K. 
(2014). Obesity and NAFLD: the role of bacteria and microbiota. Clinical Liver Disease, 18, 59-71. 
http://dx.doi.org/10.1016/j.cld.2013.09.002 
Dombrink-Kurtzman, M. A. (2008). Mycotoxins in Fruits and Vegetables. Chapter 2-Economic Aspects of 
Mycotoxins in Fruits and Vegetables, 27-44. http://dx.doi.org/10.1016/B978-0-12-374126-4.00002-4 
Engelhardt, B., & Sorokin L. (2009). The blood-brain and the blood-cerebrospinal fluid barriers: function and 
dysfunction. Seminars in Immunopathology, 31, 497-511. http://dx.doi.org/10.1007/s00281-009-0177-0 
Erickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012). 
Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid 
reabsorption, peripheral clearance and transporter function at the blood-brain barrier. Journal of 
Neuroinflammation, 9, 150. http://dx.doi.org/10.1186/1742-2094-9-150 
Feingold, K. R., Staprans, I., Memon, R. A., Moser, A. H., Shigenaga, J. K., & Doerrler, W. (1992). Endotoxin 
rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic 
triglyceride production while high doses inhibit clearance. Journal of Lipid Research, 33, 1765-76. 
Fenton, M. J., & Golenbock, D. T. (1998). LPS-binding proteins and receptors. Journal of Leukocyte Biology, 64, 
25-32. 
Guarente, L (2007). Sirtuins in Aging and Disease. Cold Spring Harbour Symposium Quantitative Biology, 72, 
483-488. http://dx.doi.org/10.1101/sqb.2007.72.024 
Gupta, H., Dai, L., Datta, G., Garber, D. W., Grenett, H., Li, Y., Mishra, V., Palgunachari, M. N., Handattu, S., 
Gianturco, S. H., & Bradley, W.A. (2005). Inhibition of lipopolysaccharide-induced inflammatory responses 
by an apolipoprotein AI mimetic peptide. Circulation Research, 97, 236-43.  
http://dx.doi.org/10.1161/01.RES.0000176530.66400.48 
Hansen, M. K., & Connolly, T. M. (2008). Nuclear Receptors as Drug Targets in Obesity, Dyslipidemia and 
Atherosclerosis. Current Opinion in Investigational Drugs, 9, 247-255. 
Harrison, C. (2012). Neurodegenerative Disorders: A Neuroprotective Role for Sirtuin 1. Nature Reviews Drug 
Discovery, 11, 108. http://dx.doi.org/10.1038/nrd3672 
Harte, A. L., da Silva, N. F., Creely, S. J., McGee, K. C., Billyard, T., & Youssef-Elabd, E. M. (2010) Elevated 
endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond), 7, 15.  
http://dx.doi.org/10.1186/1476-9255-7-15 
Henning, M. F., Garda, H. A., & Bakas, L. (2006). Biophysical characterization of interaction between 
apolipoprotein A-I and bacterial lipopolysaccharide. Cell Biochemistry Biophysica, 44, 490-6. 
http://dx.doi.org/10.1385/CBB:44:3:490 
Herskovits, A. Z., & Guarente, L. (2014). SIRT1 in Neurodevelopment and Brain Senescence. Neuron, 8, 471-483. 
http://dx.doi.org/10.1016/j.neuron.2014.01.028 
Hesse, C., Larsson, H., Fredman, P., Minthon, L., Andreasen, N., … Auty, M. A. (2015) Growth and location of 
bacterial colonies within dairy foods using microscopy techniques: a review. Front Microbiol. 6, 99. 
Hladky, S. B., & Barrand, M. A. (2014). Mechanisms of fluid movement into, through and out of the brain: 
evaluation of the evidence. Fluids Barriers Central Nervous System, 11, 26.  
http://dx.doi.org/10.1186/2045-8118-11-26 
Hottman, D. A., Chernick, D., Cheng, S., Wang, Z., & Li L. (2014). HDL and cognition in neurodegenerative 
disorders. Neurobiology of Disease, 72, 22-36. http://dx.doi.org/10.1016/j.nbd.2014.07.015 
Howel, K. (1912). Bacterial Contamination of Bread. American Journal of Public Health (N Y), 2, 321-324. 
http://dx.doi.org/10.2105/AJPH.2.5.321 
Huang, H., Liu, T., Rose, J. L., Stevens, R. L., & Hoyt, D. G. (2007) Sensitivity of mice to lipopolysaccharide is 
http://jfr.ccsenet.org Journal of Food Research Vol. 5, No. 6; 2016 
51 
 
increased by a high saturated fat and cholesterol diet. J Inflammation, 4, 22.  
http://dx.doi.org/10.1186/1476-9255-4-22 
Hymery, N., Vasseur, V., Coton, M., Mounier, J., Jany, J. L., Barbier, G., & Coton, E. (2014). Filamentous Fungi 
and Mycotoxins in Cheese: A Review. Comprehensive Reviews in Food Science and Food Safety, 13, 
437-456. http://dx.doi.org/10.1111/1541-4337.12069 
Kanwar, J. R., Sriramoju., B., & Kanwar, R. K. (2012). Neurological disorders and therapeutics targeted to 
surmount the blood–brain barrier. International Journal of Nanomedicine, 7, 3259-3278. 
http://dx.doi.org/10.2147/IJN.S30919 
Kobessho, H., Oishi, K., Hamaguchi, H., & Kanda F. (2008). Elevation of cerebrospinal fluid protein in patients 
with diabetes mellitus is associated with duration of diabetes. European Neurology, 60, 132-6. 
http://dx.doi.org/10.1159/000144083 
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., & Bevilacqua, C. (2013). Intestinal microbiota 
determines development of non-alcoholic fatty liver disease in mice. Gut, 62, 1787-94. 
http://dx.doi.org/10.1136/gutjnl-2012-303816 
Lee, C. Y. (2013). The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What 
Should be the Ideal Treatment? ClinTransl Gastroenterol, 4, e39. http://dx.doi.org/10.1038/ctg.2013.11 
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., & Oh, K.W. (2008) Neuro-inflammation induced by 
lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J 
Neuroinflammation. 5, 37. http://dx.doi.org/10.1186/1742-2094-5-37 
Leff, J. W., & Fierer, N. (2013). Bacterial Communities Associated with the Surfaces of Fresh Fruits and 
Vegetables. PLoS ONE, 8, e59310. http://dx.doi.org/10.1371/journal.pone.0059310 
Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., Heine, H., Penke, B., Neumann, H., 
& Fassbender, K. (2005). LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. 
Brain. 128, 1778-89. http://dx.doi.org/10.1093/brain/awh531 
Llewellyn, D. J., Langa, K. M., Friedland, R. P., & Lang, I. A. (2010). Serum Albumin Concentration and 
Cognitive Impairment. Curr Alzheimer Res. 7, 91-96. http://dx.doi.org/10.2174/156720510790274392 
Makun, H. S. (2013). Mycotoxin and food safety in developing countries. http://dx.doi.org/10.5772/3414 
Manschot, S. M., Biessels, G. J., Rutten, G. E., Kessels, R. P., Gispen, W. H., & Kappelle, L. J. (2008). Utrecht 
Diabetic Encephalopathy Study Group. Peripheral and central neurologic complications in type 2 diabetes 
mellitus: no association in individual patients. Journal of Neurological Science, 264, 157-62. 
http://dx.doi.org/10.1016/j.jns.2007.08.011 
Martins, I. J. (2013). Increased Risk for Obesity and Diabetes with Neurodegeneration in Developing Countries. 
Journal of Molecular Genetic Medicine, S1, 1-8. 
Martins, I. J. (2015). Diabetes and Cholesterol Dyshomeostasis Involve Abnormal α-Synuclein and Amyloid Beta 
Transport in Neurodegenerative Diseases. Austin Alzheimer’s Journal of Parkinsons Disease, 2, 1020-28. 
Martins, I. J. (2015). Diabetes and Cholesterol Dyshomeostasis Involve Abnormal α-Synuclein and Amyloid Beta 
Transport in Neurodegenerative Diseases. Austin Alzheimer’s Journal of Parkinsons Disease, 2, 1020-28. 
Martins, I. J. (2015). Diabetes and Organ Dysfunction in the Developing and Developed. World Global Journal of 
Medical Research: F Diseases, 15 Issue 1 Version 1.0. 
Martins, I. J. (2015). LPS Regulates Apolipoprotein E and Aβ Interactions with Effects on Acute Phase Proteins 
and Amyloidosis. Advances in Aging Research, 4, 69-77. http://dx.doi.org/10.4236/aar.2015.42009 
Martins, I. J. (2015). Nutritional and Genotoxic Stress Contributes to Diabetes and Neurodegenerative Diseases 
such as Parkinson's and Alzheimer's Diseases. - Frontiers in Clinical Drug Research -CNS and Neurological 
Disorders, 35, 158-192 Editor: Atta-ur-Rahman. 
Martins, I. J. (2015). Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic 
diseases and Alzheimer’s disease. Edition 1, Photon ebooks 
Martins, I. J. (2015). Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in 
Neurodegenerative Diseases. International Journal of Molecular Science, 16, 29554-29573. 
http://dx.doi.org/10.3390/ijms161226190 
Martins, I. J. (2015). Unhealthy Diets Determine Benign or Toxic Amyloid Beta States and Promote Brain 
http://jfr.ccsenet.org Journal of Food Research Vol. 5, No. 6; 2016 
52 
 
Amyloid Beta Aggregation. Austin J Clinical Neurology, 2, 1060-66. 
Martins, I. J. (2015). Unhealthy Nutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities. 
Journal of Molecular Genetic Medicine, 9, 1-11. 
Martins, I. J. (2016). Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis 
in Global Populations. Advances in Aging Research, 5, 9-26. http://dx.doi.org/10.4236/aar.2016.51002 
Martins, I. J. (2016). Bacterial Lipopolysaccharides Change Membrane Fluidity with Relevance to Phospholipid 
and Amyloid Beta Dynamics in Alzheimer’s Disease. Journal of Microbial Biochemical Technology, 8, 
322-324. http://dx.doi.org/10.4172/1948-5948.1000304 
Martins, I. J. (2016). Magnesium Therapy Prevents Senescence with the Reversal of Diabetes and Alzheimer’s 
Disease. Health, 8, 694-710. http://dx.doi.org/10.4236/health.2016.87073 
Martins, I. J. (2016). Nutrition increases Survival and Reverses NAFLD and Alzheimers disease. Ebook project.. 
Editor. Emma Jones. Acquisition Editor LAP LAMBERT Academic Publishing is a trademark of: AV 
Akademikerverlag GmbH & Co. KG.  
Martins, I. J. (2016). Type 3 diabetes with links to NAFLD and Other Chronic Diseases in the Western World. 
International Journal of Diabetes, 1, 1-5. 
Martins, I. J., & Creegan, R. (2014). Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis 
in Alzheimer’s Disease. Health, 6, 1549-1579. http://dx.doi.org/10.4236/health.2014.612190 
Miele, L., Marrone, G., Lauritano, C., Cefalo, C., Gasbarrini, A., & Day, C. (2013). Gut-liver axis and microbiota 
in NAFLD: insight pathophysiology for novel therapeutic target. Current Pharmaceutical Design, 19, 
5314-24. http://dx.doi.org/10.2174/1381612811319290011 
Nilsson, C., Ståhlberg, F., Thomsen,C., Henriksen, O., Herning, M., & Owman C. (1992). Circadian variation in 
human cerebrospinal fluid production measured by magnetic resonance imaging. American Journal of 
Physiology. 262, R20-4. 
Rodríguez-Arellano, J. J., Parpura, V., Zorec, R., & Verkhratsky, A. (2016). Astrocytes in physiological aging and 
Alzheimer's disease. Neuroscience, 323, 170-82. http://dx.doi.org/10.1016/j.neuroscience.2015.01.007 
Rosenberg, G. A. (2012). Neurological diseases in relation to the blood-brain barrier. Journal of Cerebral Blood 
Flow and Metabolism, 32, 1139-51. http://dx.doi.org/10.1038/jcbfm.2011.197 
Tang, B. L., & Chua, C. E. L. (2008). SIRT1 and neuronal diseases. Molecular Aspects of Medicine, 29, 187-200. 
http://dx.doi.org/10.1016/j.mam.2007.02.001 
Wang, Y., Zhu, X., Wu, G., Shen, L., & Chen. B. (2008). Effect of lipid-bound apoA-I cysteine mutants on 
lipopolysaccharide-induced endotoxemia in mice. Journal of Lipid Research, 49, 1640-1645.  
http://dx.doi.org/10.1194/jlr.M700446-JLR200 
WHO/Food safety/FactSheet No 399/Dec 2015, www.google.com.au 
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of 
nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. 
Hepatology, 64, 73-84. http://dx.doi.org/10.1002/hep.28431 
Yun, S., Urbanc, B., Cruz, L., Bitan, G., Teplow, D. B., & Stanley, H. E. (2007). Role of electrostatic interactions 
in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophysical 
Journal, 92, 4064-77. http://dx.doi.org/10.1529/biophysj.106.097766 
 
Copyrights 
Copyright for this article is retained by the author(s), with first publication rights granted to the journal. 
This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution 
license (http://creativecommons.org/licenses/by/4.0/). 
